NanoVibronix rises on FDA filing for next-generation pain management device

ENvue Medical

04/05/2022 15:40

** Medical device maker's shares  NAOV.O  rise 4.6% to $0.69
    ** Co submits marketing application with U.S. FDA for
Painshield Plus, its next-generation pain management device
 urn:newsml:reuters.com:*:nBwnnVH0a
    ** Device delivers ultrasound therapy for the treatment of
pain and various soft tissue injuries 
    ** Stock down ~33% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))